Bahar Aliakbarian is an expert in supply chain management in pharmaceuticals and a professor at the School of Packaging at Michigan State University. Below, she describes the vaccine supply chains of Pfizer and Moderna, which ...
Dec 4, 2020
0
2
Franco-Austrian biotech firm Valneva will supply the European Union with as many as 60 million doses of its COVID-19 vaccine under the terms of a deal announced on Wednesday.
Nov 10, 2021
0
23
(HealthDay)—A combination vaccine offered to mothers from 28 weeks of gestation may offer protection for infants born prematurely, according to a study published online June 2 in Pediatrics.
Jun 6, 2016
0
1
India will be given first priority for the delivery of the AstraZeneca/Oxford vaccine after its British developers claimed success following mass testing, the world's largest vaccine manufacturer by volume said Monday.
Nov 23, 2020
0
3
The U.S. Food and Drug Administration announced Thursday that it has asked vaccine makers to update their COVID-19 booster shots to target the omicron subvariants known as BA.4 and BA.5.
Jun 30, 2022
0
9
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Apr 28, 2021
0
1
Two new COVID-19 vaccines are due to arrive in the UK. As the country begins to emerge from lockdown, recent announcements about the Moderna and Novavax vaccines will boost confidence in its vaccination rollout.
Mar 31, 2021
0
2
Amid the COVID-19 pandemic, some people in medically underserved Latino communities avoided getting vaccinated due to fears of side effects, mistrust of health officials and vaccine manufacturers and discrimination from health ...
Nov 7, 2022
0
3
Our ongoing battles with COVID variants delta and omicron highlight just how quickly viruses can mutate, and what that can mean for public health. How quickly can we modify COVID-19 vaccines to tackle any new variants that ...
Jan 26, 2022
0
16
As scientists race to create a vaccine for the Zika virus, new research from the University of Georgia suggests almost half of Americans wouldn't be interested in getting the shot even if public health officials recommended ...
Dec 14, 2016
0
0
